Cyanobacterial electron carrier proteins as electron donors to CYP106A2 from Bacillus megaterium ATCC 13368

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 11, 2009, Pages 1635-1642

  Goñi, Guillermina ^a   Zöllner, Andy ^b   Lisurek, Michael ^b   Velázquez Campoy, Adrián ^a,c   Pinto, Sira ^a   Gómez Moreno, Carlos ^a   Hannemann, Frank ^b   Bernhardt, Rita ^b   Medina, Milagros ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b SAARLAND UNIVERSITY   (Germany)

^c FUNDACIÓN ARAID   (Spain)

Author keywords

Adrenodoxin; CYP106A2; Electron transfer; Ferredoxin; Flavodoxin; Protein protein interaction; Transient interaction

Indexed keywords

CARRIER PROTEIN; CYTOCHROME; CYTOCHROME CYP106A2; FERREDOXIN; FLAVODOXIN; UNCLASSIFIED DRUG;

ANABAENA; ARTICLE; BACILLUS MEGATERIUM; CYANOBACTERIUM; DONOR; ELECTRON; ELECTRON TRANSPORT; HYBRID; HYDROXYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REACTION ANALYSIS;

BACILLUS MEGATERIUM; BACTERIAL PROTEINS; CYANOBACTERIA; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRON TRANSPORT; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; FERREDOXINS; FLAVODOXIN; KINETICS; STEROID HYDROXYLASES; THERMODYNAMICS;

ANABAENA; BACILLUS MEGATERIUM; CYANOBACTERIA;

EID: 70249094589     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.07.012     Document Type: Article

References (63)

1. Bureik M., and Bernhardt R. In: Schmid R.D., and Urlacher V. (Eds). Modern Biooxidation (2007), Wiley-VCH, Weinheim 155-176
2. Bureik M., Lisurek M., and Bernhardt R. The human steroid hydroxylases CYP1B1 and CYP11B2. Biol. Chem. 383 (2002) 1537-1551
3. Straathof A.J., Panke S., and Schmid A. The production of fine chemicals by biotransformations. Curr. Opin. Biotechnol. 13 (2002) 548-556
4. Guengerich F.P. Cytochrome P450 enzymes in the generation of commercial products. Nat. Rev. Drug Discov. 1 (2002) 359-366
5. Bernhardt R. Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 124 (2006) 128-145
6. Manosroi J., Sripalakit P., and Manosroi A. Biotransformation of chlormadinone acetate to delmadinone acetate by free and immobilized Arthrobacter simplex ATCC 6946 and Bacillus sphaericus ATCC 13805. Enzyme Microb. Technol. 33 (2003) 320-325
7. Waterman M.R., Bernhardt R., Hildebrandt A.B., and Prough R.A. Drug metabolism reviews: preface. Drug Metab. Rev. 39 (2007) 251
8. Hannemann F., Virus C., and Bernhardt R. Design of an Escherichia coli system for whole cell mediated steroid synthesis and molecular evolution of steroid hydroxylases. J. Biotechnol. 124 (2006) 172-181
9. McLean K.J., Sabri M., Marshall K.R., Lawson R.J., Lewis D.G., Clift D., Balding P.R., Dunford A.J., Warman A.J., McVey J.P., Quinn A.M., Sutcliffe M.J., Scrutton N.S., and Munro A.W. Biodiversity of cytochrome P450 redox systems. Biochem. Soc. Trans. 33 (2005) 796-801
10. Lisurek M., Kang M.J., Hartmann R.W., and Bernhardt R. Identification of monohydroxy progesterones produced by CYP106A2 using comparative HPLC and electrospray ionisation collision-induced dissociation mass spectrometry. Biochem. Biophys. Res. Commun. 319 (2004) 677-682
11. Lisurek M., Simgen B., Antes I., and Bernhardt R. Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation. Chembiochem. 9 (2008) 1439-1449
12. Virus C., Lisurek M., Simgen B., Hannemann F., and Bernhardt R. Function and engineering of the 15beta-hydroxylase CYP106A2. Biochem. Soc. Trans. 34 (2006) 1215-1218
13. Simgen B., Contzen J., Schwarzer R., Bernhardt R., and Jung C. Substrate binding to 15β-hydroxylase (CYP106A2) probed by FT infrared spectroscopic studies of the iron ligand CO stretch vibration. Biochem. Biophys. Res. Commun. 269 (2000) 737-742
14. Agematu H., Matsumoto N., Fujii Y., Kabumoto H., Doi S., Machida K., Ishikawa J., and Arisawa A. Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system. Biosci. Biotechnol. Biochem. 70 (2006) 307-311
15. Virus C., and Bernhardt R. Molecular evolution of a steroid hydroxylating cytochrome P450 using a versatile steroid detection system for screening. Lipids 43 (2008) 1133-1141
16. + reductase with its substrates: optimal interaction for efficient electron transfer. Photosynth. Res. 79 (2004) 113-131
17. Zollner A., Nogués I., Heinz A., Medina M., Gómez-Moreno C., and Bernhardt R. Analysis of the interaction of a hybrid system consisting of bovine adrenodoxin reductase and flavodoxin from the cyanobacterium Anabaena PCC 7119. Bioelectrochemistry 63 (2004) 61-65
18. + reductase and bovine adrenodoxin. Eur. J. Biochem. 270 (2003) 726-735
19. + reductase in Anabaena: role of flavodoxin hydrophobic residues in protein-protein interactions. Biochemistry 47 (2008) 1207-1217
20. +. FEBS J. 276 (2009) 3942-3958
21. Frago S., Goni G., Herguedas B., Peregrina J.R., Serrano A., Perez-Dorado I., Molina R., Gomez-Moreno C., Hermoso J.A., Martinez-Julvez M., Mayhew S.G., and Medina M. Tuning of the FMN binding and oxido-reduction properties by neighboring side chains in Anabaena flavodoxin. Arch. Biochem. Biophys. 467 (2007) 206-217
22. Sagara Y., Wada A., Takata Y., Waterman M.R., Sekimizu K., and Horiuchi T. Direct expression of adrenodoxin reductase in Escherichia coli and the functional characterization. Biol. Pharm. Bull. 16 (1993) 627-630
23. Uhlmann H., Beckert V., Schwarz D., and Bernhardt R. Expression of bovine adrenodoxin in E. coli and site-directed mutagenesis of [2Fe-2S] cluster ligands. Biochem. Biophys. Res. Commun. 188 (1992) 1131-1138
24. Hiwatashi A., Ichikawa Y., Maruya N., Yamano T., and Aki K. Properties of crystalline reduced nicotinamide adenine dinucleotide phosphate-adrenodoxin reductase from bovine adrenocortical mitochonria. I. Physicochemical properties of holo- and apo-NADPH-adrenodoxin reductase and interaction between non-heme iron proteins and the reductase. Biochemistry 15 (1976) 3082-3090
25. Huang J.J., and Kimura T. Studies on adrenal steroid hydroxylases. Oxidation-reduction properties of adrenal iron-sulfur protein (adrenodoxin). Biochemistry 12 (1973) 406-409
26. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239 (1964) 2370-2378
27. Zollner A., Hannemann F., Lisurek M., and Bernhardt R. Deletions in the loop surrounding the iron-sulfur cluster of adrenodoxin severely affect the interactions with its native redox partners adrenodoxin reductase and cytochrome P450(scc) (CYP11A1). J. Inorg. Biochem. 91 (2002) 644-654
28. Uhlmann H., Iametti S., Vecchio G., Bonomi F., and Bernhardt R. Pro108 is important for folding and stabilization of adrenal ferredoxin, but does not influence the functional properties of the protein. Eur. J. Biochem. 248 (1997) 897-902
29. Nogués I., Campos L.A., Sancho J., Gómez-Moreno C., Mayhew S.G., and Medina M. Role of neighboring FMN side chains in the modulation of flavin reduction potentials and in the energetics of the FMN:apoprotein interaction in Anabaena flavodoxin. Biochemistry 43 (2004) 15111-15121
30. Muller A., Muller J.J., Muller Y.A., Uhlmann H., Bernhardt R., and Heinemann U. New aspects of electron transfer revealed by the crystal structure of a truncated bovine adrenodoxin, Adx(4-108). Structure 6 (1998) 269-280
31. Muller J.J., Muller A., Rottmann M., Bernhardt R., and Heinemann U. Vertebrate-type and plant-type ferredoxins: crystal structure comparison and electron transfer pathway modelling. J. Mol. Biol. 294 (1999) 501-513
32. Bruschi M., and Guerlesquin F. Structure, function and evolution of bacterial ferredoxins. FEMS Microbiol. Rev. 4 (1988) 155-175
33. Grinberg A.V., Hannemann F., Schiffler B., Muller J., Heinemann U., and Bernhardt R. Adrenodoxin: structure, stability, and electron transfer properties. Proteins 40 (2000) 590-612
34. Muller J.J., Lapko A., Bourenkov G., Ruckpaul K., and Heinemann U. Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J. Biol. Chem. 276 (2001) 2786-2789
35. Uhlmann H., Kraft R., and Bernhardt R. C-terminal region of adrenodoxin affects its structural integrity and determines differences in its electron transfer function to cytochrome P-450. J. Biol. Chem. 269 (1994) 22557-22564
36. Hannemann F., Rottmann M., Schiffler B., Zapp J., and Bernhardt R. The loop region covering the iron-sulfur cluster in bovine adrenodoxin comprises a new interaction site for redox partners. J. Biol. Chem. 276 (2001) 1369-1375
37. (+) reductase. Biochim. Biophys. Acta 1787 (2009) 144-154
38. + reductase with ferredoxin and flavodoxin. Proteins 72 (2008) 848-862
39. Heinz A., Hannemann F., Müller J.J., Heinemann U., and Bernhardt R. The interaction domain of the redox protein Adrenodoxin is mandatory for the binding of the electron acceptor CYP11A1, but is not required for the binding of the electron donor Adrenodoxin reductase. Biochem. Biophys. Res. Commun. 338 (2005) 491-498
40. Hannemann F., Bera A.K., Fischer B., Lisurek M., Teuchner K., and Bernhardt R. Unfolding and conformational studies on bovine adrenodoxin probed by engineered intrinsic tryptophan fluorescence. Biochemistry 41 (2002) 11008-11016
41. Schiffler B., Kiefer M., Wilken A., Hannemann F., Adolph H.W., and Bernhardt R. The interaction of bovine adrenodoxin with CYP11A1 (cytochrome P450scc) and CYP11B1 (cytochrome P45011beta). Acceleration of reduction and substrate conversion by site-directed mutagenesis of adrenodoxin. J. Biol. Chem. 276 (2001) 36225-36232
42. Bichet A., Hannemann F., Rekowski M., and Bernhardt R. A new application of the yeast two-hybrid system in protein engineering. Protein Eng. Des. Sel. 20 (2007) 117-123
43. Hannemann F., Guyot A., Zöllner A., Müller J.J., Heinemann U., and Bernhardt R. The dipole moment of the electron carrier adrenodoxin is not critical for redox partner interaction and electron transfer. J. Inorg. Biochem. 103 (2009) 997-1004
44. Zollner A., Kagawa N., Waterman M.R., Nonaka Y., Takio K., Shiro Y., Hannemann F., and Bernhardt R. Purification and functional characterization of human 11beta hydroxylase expressed in Escherichia coli. FEBS J. 275 (2008) 799-810
45. Beilke D., Weiss R., Lohr F., Pristovsek P., Hannemann F., Bernhardt R., and Ruterjans H. A new electron transport mechanism in mitochondrial steroid hydroxylase systems based on structural changes upon the reduction of adrenodoxin. Biochemistry 41 (2002) 7969-7978
46. Lambeth J.D., Seybert D.W., and Kamin H. Ionic effects on adrenal steroidogenic electron transport. The role of adrenodoxin as an electron shuttle. J. Biol. Chem. 254 (1979) 7255-7264
47. Hanukoglu I., and Jefcoate C.R. Mitochondrial cytochrome P-450sec. Mechanism of electron transport by adrenodoxin. J. Biol. Chem. 255 (1980) 3057-3061
48. Lambeth J.D., Seybert D.W., Lancaster Jr. J.R., Salerno J.C., and Kamin H. Steroidogenic electron transport in adrenal cortex mitochondria. Mol. Cell. Biochem. 45 (1982) 13-31
49. Turko I.V., Adamovich T.B., Kirillova N.M., Usanov S.A., and Chashchin V.L. Cross-linking studies of the cholesterol hydroxylation system from bovine adrenocortical mitochondria. Biochim. Biophys. Acta 996 (1989) 37-42
50. Hara T., and Takeshima M. In: Lechner M.C. (Ed). 8th International Conference (1994), Libbey Eurotext, Paris 417-420
51. Light D.R., and Orme-Johnson N.R. Beef adrenal cortical cytochrome P-450 which catalyzes the conversion of cholesterol to pregnenolone. Oxidation-reduction potentials of the free, steroid-complexed, and adrenodoxin-complexed P-450. J. Biol. Chem. 256 (1981) 343-350
52. Behlke J., Ristau O., Müller E., Hannemann F., and Bernhardt R. Self-association of adrenodoxin studied by using analytical ultracentrifugation. Biophys. Chem. 125 (2007) 159-165
53. Beckert V., and Bernhardt R. Specific aspects of electron transfer from adrenodoxin to cytochromes P450scc and P45011beta. J. Biol. Chem. 272 (1997) 4883-4888
54. Munro A.W., Girvan H.M., and McLean K.J. Cytochrome P450-redox partner fusion enzymes. Biochim. Biophys. Acta 1770 (2007) 345-359
55. Jenkins C.M., and Waterman M.R. Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities. J. Biol. Chem. 269 (1994) 27401-27408
56. Hawkes D.B., Adams G.W., Burlingame A.L., Ortiz de Montellano P.R., and De Voss J.J. Cytochrome P450(cin) (CYP176A), isolation, expression, and characterization. J. Biol. Chem. 277 (2002) 27725-27732
57. Lawson R.J., von Wachenfeldt C., Haq I., Perkins J., and Munro A.W. Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI. Biochemistry 43 (2004) 12390-12409
58. Seth-Smith H.M., Rosser S.J., Basran A., Travis E.R., Dabbs E.R., Nicklin S., and Bruce N.C. Cloning, sequencing, and characterization of the hexahydro-1,3,5-Trinitro-1,3,5-triazine degradation gene cluster from Rhodococcus rhodochrous. Appl. Environ. Microbiol. 68 (2002) 4764-4771
59. Fantuzzi A., Meharenna Y.T., Briscoe P.B., Guerlesquin F., Sadeghi S.J., and Gilardi G. Characterisation of the electron transfer and complex formation between flavodoxin from D. vulgaris and the haem domain of cytochrome P450 BM3 from B. megaterium. Biochim. Biophys. Acta 1787 (2009) 234-241
60. + reductase. Role of Trp(57) and Tyr(94). J. Biol. Chem. 277 (2002) 22338-22344
61. + reductase for site-specific ferredoxin mutants. Biochemistry 36 (1997) 11100-11117
62. + and NADPH. J. Biol. Chem. 251 (1976) 4299-4306
63. Lambeth J.D., McCaslin D.R., and Kamin H. Adrenodoxin reductase-adrenodexin complex. J. Biol. Chem. 251 (1976) 7545-7550